Blue Sparrow LLC’s AbbVie ABBV Stock Holding History

Blue Sparrow LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$64.3M	Sell	255,700 -93,800	-27%	-$20.2M	0.62%	37
2026 Q1	$76M	Buy	349,500 +224,500	+180%	+$49.8M	1.3%	17
2025 Q4	$28.6M	Buy	+125,000	New	+$28.5M	0.54%	32

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Blue Sparrow LLC's ABBV Position: Q2 2026 in Review

Blue Sparrow LLC reduced its AbbVie (ABBV) stake by 27% in Q2 2026, selling an estimated $20.2M and leaving 255,700 shares worth $64.3M. The position accounts for 0.62% of the portfolio, ranked #37.

Blue Sparrow LLC first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $76M in Q1 2026. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Blue Sparrow LLC held 255,700 shares of AbbVie worth $64.3M as of Q2 2026.
Blue Sparrow LLC sold 93,800 AbbVie shares in Q2 2026, an estimated $20.2M.
AbbVie made up 0.62% of Blue Sparrow LLC's portfolio in Q2 2026, its #37 holding.
Blue Sparrow LLC first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
Blue Sparrow LLC's AbbVie position peaked at $76M in Q1 2026.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Blue Sparrow LLC's 13F filing for Q2 2026, filed 14 Aug 2026.